A new function of the splicing factor srsf2 in the control of e2f1-mediated cell cycle progression in neuroendocrine lung tumors

Cell Cycle

Volumn 12, Issue 8, 2013, Pages 1267-1278

  Edmond, Valerie ^a,b,c   Merdzhanova, Galina ^a,b,d   Gout, Stephanie ^a,b   Brambilla, Elisabeth ^a,b   Gazzeri, Sylvie ^a,b   Eymin, Beatrice ^a,b  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d CEA GRENOBLE   (France)

Author keywords

AKT; Cellular proliferation; E2F1; Neuroendocrine lung tumors; P45SKP2; SRSF2

Indexed keywords

CYCLIN E; PROTEIN; PROTEIN KINASE B; SRSF2 PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; NEUROENDOCRINE TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84876254595     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24363     Document Type: Article

References (30)

1. Blais A, Dynlacht BD. Hitting their targets: An emerging picture of E2F and cell cycle control. Curr Opin Genet Dev 2004; 14:527-32; PMID:15380244; http://dx.doi.org/10.1016/j.gde.2004.07.003
2. Dimova DK, Dyson NJ. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 2005; 24:2810-26; PMID:15838517; http://dx.doi.org/10. 1038/sj.onc.1208612
3. DeGregori J, Johnson DG. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. Curr Mol Med 2006; 6:739-48; PMID:17100600
4. Johnson DG, Degregori J. Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr Mol Med 2006; 6:731-8; PMID:17100599
5. Harbour JW, Dean DC. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 2000; 14:2393-409; PMID:11018009; http://dx.doi.org/10. 1101/gad.813200
6. Jumaa H, Wei G, Nielsen PJ. Blastocyst formation is blocked in mouse embryos lacking the splicing factor SRp20. Curr Biol 1999; 9:899-902; PMID:10469594; http://dx.doi.org/10.1016/S0960-9822(99)80394-7
7. Wang HY, Xu X, Ding JH, Bermingham JR Jr., Fu XD. SC35 plays a role in T cell development and alternative splicing of CD45. Mol Cell 2001; 7:331-42; PMID:11239462; http://dx.doi.org/10.1016/S1097-2765(01)00181-2
8. Ding JH, Xu X, Yang D, Chu PH, Dalton ND, Ye Z, et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. EMBO J 2004; 23:885-96; PMID:14963485; http://dx.doi.org/10.1038/sj.emboj.7600054
9. Lin S, Xiao R, Sun P, Xu X, Fu XD. Dephosphorylationdependent sorting of SR splicing factors during mRNP maturation. Mol Cell 2005; 20:413-25; PMID:16285923; http://dx.doi.org/10.1016/j.molcel. 2005.09.015
10. Rasheva VI, Knight D, Bozko P, Marsh K, Frolov MV. Specific role of the SR protein splicing factor B52 in cell cycle control in Drosophila. Mol Cell Biol 2006; 26:3468-77; PMID:16611989; http://dx.doi.org/10.1128/MCB.26.9.3468- 3477.2006
11. Xiao R, Sun Y, Ding JH, Lin S, Rose DW, Rosenfeld MG, et al. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol 2007; 27:5393-402; PMID:17526736; http://dx.doi.org/10.1128/MCB.00288-07
12. Eymin B, Gazzeri S, Brambilla C, Brambilla E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene 2001; 20:1678-87; PMID:11313916; http://dx.doi.org/10.1038/ sj.onc.1204242
13. Salon C, Merdzhanova G, Brambilla C, Brambilla E, Gazzeri S, Eymin B. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors. Oncogene 2007; 26:6927-36; PMID:17471231; http://dx.doi.org/10.1038/sj.onc.1210499
14. Merdzhanova G, Edmond V, De Seranno S, Van den Broeck A, Corcos L, Brambilla C, et al. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death Differ 2008; 15:1815-23; PMID:18806759; http://dx.doi.org/10.1038/cdd.2008.135
15. Gout S, Brambilla E, Boudria A, Drissi R, Lantuejoul S, Gazzeri S, et al. Abnormal expression of the premRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma. PLoS ONE 2012; 7:e46539; PMID:23071587; http://dx.doi.org/10.1371/journal.pone.0046539
16. Blaustein M, Pelisch F, Tanos T, Muñoz MJ, Wengier D, Quadrana L, et al. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 2005; 12:1037-44; PMID:16299516; http://dx.doi.org/10.1038/nsmb1020
17. Hallstrom TC, Mori S, Nevins Jr. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 2008; 13:11-22; PMID:18167336; http://dx.doi.org/10.1016/j.ccr.2007.11.031
18. Ahn EY, DeKelver RC, Lo MC, Nguyen TA, Matsuura S, Boyapati A, et al. SON controls cell-cycle progression by coordinated regulation of RNA splicing. Mol Cell 2011; 42:185-98; PMID:21504830; http://dx.doi.org/10.1016/j.molcel.2011.03. 014
19. Lin S, Coutinho-Mansfield G, Wang D, Pandit S, Fu XD. The splicing factor SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol 2008; 15:819-26; PMID:18641664; http://dx.doi.org/10.1038/nsmb.1461
20. Cramer P, Cáceres JF, Cazalla D, Kadener S, Muro AF, Baralle FE, et al. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 1999; 4:251-8; PMID:10488340; http://dx.doi.org/10.1016/S1097-2765(00)80372-X
21. Auboeuf D, Dowhan DH, Kang YK, Larkin K, Lee JW, Berget SM, et al. Differential recruitment of nuclear receptor coactivators may determine alternative RNA splice site choice in target genes. Proc Natl Acad Sci USA 2004; 101:2270-4; PMID:14982999; http://dx.doi.org/10.1073/pnas.0308133100
22. Auboeuf D, Hönig A, Berget SM, O'Malley BW. Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 2002; 298:416-9; PMID:12376702; http://dx.doi.org/10.1126/science. 1073734
23. Furger A, O'Sullivan JM, Binnie A, Lee BA, Proudfoot NJ. Promoter proximal splice sites enhance transcription. Genes Dev 2002; 16:2792-9; PMID:12414732; http://dx.doi.org/10.1101/gad.983602
24. Kwek KY, Murphy S, Furger A, Thomas B, O'Gorman W, Kimura H, et al. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat Struct Biol 2002; 9:800-5; PMID:12389039
25. Damgaard CK, Kahns S, Lykke-Andersen S, Nielsen AL, Jensen TH, Kjems J. A 5' splice site enhances the recruitment of basal transcription initiation factors in vivo. Mol Cell 2008; 29:271-8; PMID:18243121; http://dx.doi.org/10. 1016/j.molcel.2007.11.035
26. Edmond V, Moysan E, Khochbin S, Matthias P, Brambilla C, Brambilla E, et al. Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO J 2011; 30:510-23; PMID:21157427; http://dx.doi.org/10.1038/emboj.2010.333
27. Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012; 44:1104-10; PMID:22941188; http://dx.doi.org/10.1038/ng.2396
28. Salon C, Eymin B, Micheau O, Chaperot L, Plumas J, Brambilla C, et al. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptormediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ 2006; 13:260-72; PMID:16052233; http://dx.doi.org/10.1038/sj.cdd.4401739
29. Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res 2007; 67:4149-56; PMID:17483325; http://dx.doi.org/10.1158/0008-5472.CAN-06-4484
30. Cartier J, Berthelet J, Marivin A, Gemble S, Edmond V, Plenchette S, et al. Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription. J Biol Chem 2011; 286:26406-17; PMID:21653699; http://dx.doi.org/10.1074/jbc.M110.191239